AMEXInformation TechnologySoftware - ApplicationSnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|---|---|
| Quarter ending 2026-12-30 | ||
| Revenue | — | 4.66M |
| EPS | — | -0.08 |
| Annual ending 2026-12-31 | ||
| Revenue | — | 19M |
| EPS | — | -0.29 |
Management figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
successful execution of CEO transition and strategy | A primary condition in Intellinetics Inc's published investment case. The stated target is clear progress on turnaround milestones by end of 2026. | Under Pressure | no meaningful progress or worsening results by end of 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
move toward profitability and positive free cash flow | A primary condition in Intellinetics Inc's published investment case. The stated target is reduce losses and improve free cash flow by at least 50% in FY26. | Broken | losses widen or free cash flow remains near zero or negative in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
double-digit year-over-year SaaS revenue growth | The company targets double-digit SaaS growth in fiscal 2026. | Broken | SaaS revenue growth falls below 5% YoY in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 2 of last 2 quarters. SaaS revenue grew modestly by 0.1% in 2026-Q1 and by 4.2% in 2026-Q2 year over year. Management targets double-digit SaaS growth for fiscal 2026, but current growth is below that target, indicating limited progress so far. Delivery assessment Oct 24, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 11, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative turnaround thesis, not a proven durable compounder. The multi-year view is on watch: management has named clear priorities, but results so far show limited delivery, and confidence in the thesis has fallen to medium.
INLX is described as cheap versus peers, while the model also indicates a 31% premium versus peers and has low confidence. The expectations gap is negative, and the priced-in assessment is tagged as justified, with low fragility; the evidence does not show a clear case that expectations are unusually low.
Near term, results remain weak: total revenue declined year over year in both reported quarters, while SaaS growth improved from 0.1% to 4.2% but remains below management's double-digit fiscal 2026 target. Management reports better forecasting and pipeline practices, but measurable revenue delivery and the impact of product investment remain limited; recent CEO and strategy leadership transitions add uncertainty.
The multi-year thesis depends on whether SaaS growth accelerates and operational changes translate into stronger revenue. Near term, a guidance cut would be a meaningful negative; Fed rate cuts and continued strong results from sector peers such as SAP, CRM, and NOW are potential favorable conditions, but do not establish company-level progress.
Over the next 1 to 3 years, INLX is a high-risk turnaround case whose thesis needs stronger growth and execution evidence. Recent performance is weak, and the expectations picture is mixed. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.